The relationship between antiretroviral prescription patterns and treatment guidelines in treatment-naïve HIV-1-infected patients

HIV Medicine

Volumn 10, Issue 9, 2009, Pages 573-579

  Suarez Lozano, I ^a   Viciana, P ^b   Lacalle, J R ^c   Teira, R ^d   Lozano, F ^e   Lopez Aldeguer, J ^f   Pedrol, E ^g   Domingo, P ^h   Cosin, J ⁱ   Roca, B ^j   Geijo, P ^k   Fuente, B ^l   Vergara, A ^m   Ribera, E ⁿ   Galindo, M J ^o   Zapata, A ^p   Sanchez, T ^q   Vidal, F ^r   Munoz Sanz, A ^s   Munoz Sanchez, J ^t   Garrido, M ^u   more..

^a HOSPITAL INFANTA ELENA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

^d HOSPITAL SIERRALLANA   (Spain)

^e HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

^g HOSPITAL GENERAL DE GRANOLLERS   (Spain)

^h Hospital S Creu i S Pau   (Spain)

ⁱ HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^j HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^k HOSPITAL VIRGEN DE LA LUZ   (Spain)

^l HOSPITAL DE CABUEÑES   (Spain)

^m HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

ⁿ HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^o HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^p HOSPITAL DE JEREZ   (Spain)

^q Digestive Service   (Spain)

^r HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^s HOSPITAL INFANTA CRISTINA   (Spain)

^t HOSPITAL DE BASURTO   (Spain)

^u AM VACH   (Spain)

more..

Author keywords

ART; Guidelines; HIV

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGE; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL DECISION MAKING; DRUG CHOICE; FEMALE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SPAIN; VIRUS LOAD;

ADULT; AGED; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; GUIDELINE ADHERENCE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; SPAIN; TIME FACTORS; VIRAL LOAD;

EID: 70349997497     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2009.00731.x     Document Type: Article

References (22)

1. Browman GP. Development and aftercare of clinical guidelines. JAMA 2001, 286:1509-1511.
2. Lomas J, Anderson GM, Domnick-Pierre K, Vayda E, Enkin MW, Hannah WJ. Do practice guidelines guide practice?. N Engl J Med 1989, 321:1306-1311.
3. Siegel D, Lopez J. Trends in antihypertensive drug use in the United States. JAMA 1997, 278:1745-1748.
4. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of b-blockers in elderly survivors of acute myocardial infarction. JAMA 1997, 277:115-121.
5. Rockall TA, Logan R, Devlin H, Northfield T. Influencing the practice and outcome in acute upper gastrointestinal haemorrhage. Gut 1997, 41:606-611.
6. Parikh MJ, Cheng L, Nieman LZ, Grimes RM. Medical treatment of women and adherence to HIV guidelines at an urban university-staffed public clinic. J Womens Health (Larchmt) 2003, 12:897-902.
7. Sabin CA, Lampe FC, Chaloner C. An audit of antiretroviral treatment use in HIV-infected patients in a London clinic. HIV Med 2003, 4:87-93.
8. Carmody ER, Diaz T, Starling P, dos Santos AP, Sacks HS. An evaluation of antiretroviral HIV/AIDS treatment in a Rio de Janeiro public clinic. Trop Med Int Health 2003, 8:378-385.
9. Curtis H, Sabin CA, Johnson MA. Findings from the first national clinical audit of treatment for people with HIV. HIV Med 2003, 4:11-17. for the British HIV Association Clinical Audit Committee.
10. Holodniy M, Hornberger J, Rapoport D. Relationship between antiretroviral prescribing patterns and treatment guidelines in treatment-naïve HIV-1-infected US veterans (1992-2004). J Acquir Immune Defic Syndr 2007, 44:20-29.
11. Cocohoba J, Wang OJ, Cox C. Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected women. J Acquir Immune Defic Syndr 2008, 47:377-383.
12. Easterbrook PJ, Phillips AN, Hill T. Patterns and predictors of the use of different antiretroviral drug regimens at treatment initiation in the UK. HIV Med 2008, 9:47-56.
13. 1993 revision of the European AIDS surveillance case definition. AIDS Surveill Eur Quart Rep 1993, 37:23-28. European Centre for Epidemiological Monitoring AIDS.
14. Suarez-Lozano I, Fajardo JM, Garrido M. Epidemiological trends of HIV infection in Spain. AIDS 2002, 16:2496-2499.
15. Teira R, Suárez-Lozano I, Muñoz P. Patrón epidemiológico de la infección por el VIH en 15 hospitales españoles. Enferm Infecc Microbiol Clin 2005, 23:213-217.
16. Rubio R, Berenguer J, Miró JM. Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en pacientes adultos infectados por el virus de la inmunodeficiencia humana en el año 2002. Enferm Infecc Microbiol Clin 2002, 20:244-303.
17. Iribarren JA, Labarga P, Rubio R. Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en pacientes adultos infectados por el VIH (octubre 2004). Enferm Infecc Microbiol Clin 2004, 22:564-642.
18. Brook MG, Curtis H, Johnson MA. Findings from the British HIV Association's national clinical audit of first-line antiretroviral therapy and survey of treatment practice and maternity care, 2002. HIV Med 2004, 5:415-420. for the British HIV Association Clinical Audit Committee.
19. Stöhr W, Dunn DT, Porter K. CD4 cell count and initiation of antiretroviral therapy. HIV Med 2007, 8:135-141. UK CHIC Study.
20. Egger M, May M, Chene G. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy. Lancet 2002, 360:119-129.
21. Loo VS, Diaz T, Gadelha AM. Managing HIV-infected patients on antiretroviral therapy in Rio de Janeiro, Brazil. AIDS Care 2004, 16:834-840.
22. Worrall G, Chaulk P, Freake D. The effects of clinical practice guidelines on patient outcomes in primary care. Can Med Assoc J 1997, 156:1705-1712.